volume 2, issue 8, PS450-S451 2007
DOI: 10.1097/01.jto.0000283379.01457.db
View full text
|
|
Share

Abstract: Concurrent chemoradiotherapy has become the standard treatment for unresectable locally advanced non-small cell lung cancer (NSCLC). However, distant metastases remain the major site of failure.Here we report a randomized phase II trial of consolidation chemotherapy with monthly paclitaxel and cisplatin (PC) or observation after concurrent chemoradiotherapy in patients with locally advanced NSCLC to evaluate the feasibility and the role of consolidation chemotherapy. Methods: Between March 2000 and August 2002…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
2
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals